Insufficient scRNA-seq data for expression of SERPINA3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
liver | 100% | 359572.13 | 226 / 226 | 86% | 7.63 | 349 / 406 |
pancreas | 99% | 217487.83 | 324 / 328 | 66% | 4.02 | 117 / 178 |
breast | 81% | 27917.45 | 373 / 459 | 70% | 4.77 | 788 / 1118 |
prostate | 77% | 43456.36 | 189 / 245 | 41% | 2.40 | 205 / 502 |
lung | 88% | 12509.18 | 507 / 578 | 18% | 0.60 | 205 / 1155 |
esophagus | 61% | 6561.48 | 884 / 1445 | 34% | 1.45 | 63 / 183 |
ovary | 88% | 12403.06 | 158 / 180 | 6% | 0.29 | 25 / 430 |
bladder | 86% | 14452.29 | 18 / 21 | 6% | 0.16 | 28 / 504 |
stomach | 72% | 16672.57 | 260 / 359 | 14% | 0.80 | 39 / 286 |
brain | 33% | 5941.91 | 865 / 2642 | 48% | 2.46 | 336 / 705 |
blood vessel | 73% | 10964.44 | 969 / 1335 | 0% | 0 | 0 / 0 |
heart | 68% | 10018.20 | 583 / 861 | 0% | 0 | 0 / 0 |
intestine | 58% | 4901.84 | 561 / 966 | 7% | 0.46 | 39 / 527 |
kidney | 55% | 13095.25 | 49 / 89 | 6% | 0.20 | 56 / 901 |
thymus | 55% | 5252.66 | 362 / 653 | 0% | 0.00 | 2 / 605 |
adrenal gland | 46% | 3624.94 | 119 / 258 | 5% | 0.10 | 12 / 230 |
adipose | 47% | 4273.14 | 569 / 1204 | 0% | 0 | 0 / 0 |
uterus | 33% | 2591.70 | 56 / 170 | 11% | 0.37 | 49 / 459 |
skin | 24% | 1830.98 | 427 / 1809 | 20% | 0.87 | 93 / 472 |
muscle | 39% | 6863.01 | 315 / 803 | 0% | 0 | 0 / 0 |
spleen | 13% | 1891.90 | 32 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
peripheral blood | 1% | 156.93 | 7 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0019216 | Biological process | regulation of lipid metabolic process |
GO_0006953 | Biological process | acute-phase response |
GO_0006954 | Biological process | inflammatory response |
GO_0030277 | Biological process | maintenance of gastrointestinal epithelium |
GO_0010951 | Biological process | negative regulation of endopeptidase activity |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0005615 | Cellular component | extracellular space |
GO_0072562 | Cellular component | blood microparticle |
GO_0070062 | Cellular component | extracellular exosome |
GO_0031093 | Cellular component | platelet alpha granule lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0034774 | Cellular component | secretory granule lumen |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SERPINA3 |
Protein name | Serpin A3 isoform N Serpin A3 isoform T Serpin family A member 3 Serpin family A member 3 (Serpin peptidase inhibitor, clade A (Alpha-1 antiproteinase, antitrypsin), member 3, isoform CRA_a) Alpha-1-antichymotrypsin (ACT) (Cell growth-inhibiting gene 24/25 protein) (Serpin A3) [Cleaved into: Alpha-1-antichymotrypsin His-Pro-less] |
Synonyms | GIG25 GIG24 hCG_2039549 AACT |
Description | FUNCTION: Although its physiological function is unclear, it can inhibit neutrophil cathepsin G and mast cell chymase, both of which can convert angiotensin-1 to the active angiotensin-2. . |
Accessions | ENST00000621603.1 ENST00000556968.2 [P01011-2] ENST00000393080.8 [P01011-1] ENST00000393078.5 [P01011-1] P01011 A0A977TIE0 G3V595 G3V3A0 ENST00000467132.5 [P01011-1] A0A087WY93 ENST00000482740.2 A0A977TIE2 ENST00000555820.1 |